US-headquartered blockchain security player CertiK with significant operations in China raised $37 million in its Series B round. In a separate development, Westlake Therapeutics has bagged 100 million yuan ($15 million) in a new round.
CertiK bags $37m in Series B
US-headquartered blockchain security player CertiK with significant operations in China raised $37 million in its Series B round, per a company statement on Thursday.